Efficacy and safety of rivaroxaban plus clopidogrel versus aspirin plus clopidogrel in patients with coronary atherosclerotic heart disease and gastrointestinal disease undergoing percutaneous coronary intervention: study protocol for a non-inferiority randomized controlled trial.
Tienan ZhouYinghui GongJingyuan LiYasong WangXiao-Zeng WangPublished in: Trials (2023)
This protocol is registered at the Chinese Clinical Trial Registry under the number ChiCTR2100044319. And this publication is based on version 1.4 of the trial protocol dated Sep 6, 2021.
Keyphrases
- percutaneous coronary intervention
- randomized controlled trial
- antiplatelet therapy
- study protocol
- acute coronary syndrome
- coronary artery disease
- clinical trial
- st segment elevation myocardial infarction
- acute myocardial infarction
- st elevation myocardial infarction
- atrial fibrillation
- coronary artery bypass grafting
- phase ii
- phase iii
- cardiovascular events
- coronary artery
- venous thromboembolism
- open label
- low dose
- coronary artery bypass
- psychometric properties
- pulmonary embolism
- pulmonary hypertension
- double blind
- type diabetes
- aortic valve